膳食脂肪酸构成对小鼠淋巴细胞功能和脂质过氧化的影响

目的:探讨膳食多不饱和脂肪酸n-6/n-3比值对小鼠T淋巴细胞功能和脂质过氧化的影响。方法:96只BALb/c小鼠随机分为8组:饱和脂肪酸:单不饱和脂肪酸:多不饱和脂肪酸(S∶M∶P)为1:1.5:3.7和1:1.5:1,n-6/n-3比值分别为1、7.5、15、30,各4组。基础饲料采用AIN-93G配方,各组饲料的脂肪酸构成以食用油脂调配。饲养12w。测定小鼠T淋巴细胞功能,IL-2和血清丙二醛(MDA)水平。结果:S:M:P为1:1.5∶3.7,n-6/n-3为1时,小鼠T淋巴细胞增殖活性、IL-2水平均显著降低(P<0.05),且两者显著正相关(r=0.438,P<0.05),n-6/n-3为1、30时,血清MDA水平明显高于n-6/n-3为7.5和15组(P<0.05);S:M:P为1:1.5:1,n-6/n-3为1时,小鼠T淋巴细胞增殖活性、CD4+/CD8+T细胞比例、IL-2水平明显降低(P<0.05),n-6/n-3为1、30时,血清MDA水平明显高于n-6/n-3为7.5组(P<0.05)。结论:S:M:P为1:1.5:3.7和1:1.5:1,n-6/n-3为1时,T淋巴细胞功能受到抑制,其作用机制可能与IL-2有关;DHA对CD4+/CD8+T细胞比例的抑制作用可能大于ALA;结合脂质过氧化程度来考虑,膳食n-6/n-3为7.5～15范围内较为理想。     

不同n-6/n-3脂肪酸构成对小鼠心血管疾病危险因素的影响

目的研究不同脂肪酸构成对小鼠血脂代谢、炎症和氧化应激及内皮细胞功能的影响。方法雄性KM小鼠随机分为5组,分别喂饲正常对照饲料、猪油高脂饲料和n-6/n-3多不饱和脂肪酸(PUFA)比值为1∶1、5∶1、20∶1的高脂饲料5周,比较各组小鼠血清中甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、白介素-6(IL-6)、丙二醛(MDA)、超敏C反应蛋白(hsCRP)、肿瘤坏死因子(TNF-α)、脂质过氧化物(LPO)、8-异前列腺素F2α(8-isoPGF2α)、氧化型低密度脂蛋白(ox-LDL)、游离脂肪酸(FFA)、选择素(ES)和血管性血友病因子(v WF)的含量变化。结果猪油组LDL-C和非高密度脂蛋白胆固醇(non-HDL-C)水平显著高于其他各组(P0.05)。n-6/n-3 PUFA 1∶1组和5∶1组血清TG、TC水平显著低于猪油组(P0.05)。20∶1组血清FFA水平显著高于1∶1组和5∶1组(P0.05)。1∶1组和5∶1组血清炎症因子和氧化应激指标及ES水平均显著低于猪油组和20∶1组(P0.05)。5∶1组血清v WF水平显著低于猪油组和20∶1组(P0.05)。结论与猪油和高n-6/n-3 PUFA比值高脂饲料相比较,低n-6/n-3PUFA比值高脂饲料可改善小鼠脂代谢、炎症与氧化应激和内皮细胞功能。     

广州成人膳食n-6/n-3脂肪酸比值与心血管疾病危险因素的关系

目的分析广州40～65岁居民膳食n-6/n-3脂肪酸比值与心血管疾病危险因素的关系。方法 40～65岁广州市民1133人,采用定量食物频数问卷调查对象的每日摄入食物种类和数量,计算能量和营养素摄入量,检测其红细胞膜脂肪酸构成、血脂及颈动脉内中膜厚度(IMT),分析n-6/n-3比值大小高Q3,中Q2,低Q1与血压、血脂和IMT的关系。结果 995人资料完整纳入分析。对象日均膳食总能量摄入为9.10±2.09MJ、脂肪供能比为(34.3±7.9)%。膳食n-6/n-3脂肪酸比值为(29.74±22.71):1,红细胞膜n-6/n-3脂肪酸比值为(2.7±1.0):1,膳食SFA:MUFA:PUFA为1:1.5:1。膳食n-3脂肪酸摄入量与红细胞膜n-3构成比、膳食n-6/n-3比值与红细胞膜n-6/n-3比值均呈显著正相关关系。膳食n-6/n-3比值最高组Q3(>31.16)对象的收缩压、TC和IMT水平显著高于最低组Q1(<17.40);红细胞膜n-6/n-3比值最高组Q3(>3.04)和中间组Q2(2.18～3.03)对象的收缩压、舒张压、TC、LDL-C及IMT水平均显著高于最低组Q1(≤2.17)。结论广州市40～65岁居民膳食n-6/n-3脂肪酸比值约为30:1;该比值小于17.40:1时,有较低的血压,总胆固醇及IMT水平。     

不同n-3/n-6多不饱和脂肪酸构成比膳食对大鼠一磷酸腺苷活化蛋白激酶表达的影响

目的研究不同n-3/n-6配比脂肪酸对大鼠磷酸腺苷酸活化蛋白激酶(AMP-activated protein kinase,AMPK)蛋白及活性表达的影响。方法58只SD大鼠适应性喂养7d后,尾静脉取血。根据血清总胆固醇水平随机分为:空白(基础饲料);高脂(高脂饲料);高脂1:1(高脂饲料+n-3/n-6=1:1配方油);高脂1:5(高脂饲料+n3/n6=1:5配方油);低脂1:1(脱脂基础饲料+n-3/n-6=1:1配方油);低脂1:5(脱脂基础饲料+n3/n6=1:5配方油)6组,喂养45d,观察大鼠摄食与体重增长。于实验前1d,15d,30d,45d分别各取血测血清总胆固醇水平,于D45处死动物。Western blotting分别分析肝和下丘脑组织中AMPK-α总蛋白及其活性表达。结果添加PUFA的4个比例组血清TC、体重与高脂组相比,显著降低,且低脂2个比例组和高脂1:1组均与高脂1:5组相比有显著差异。添加PUFA的4个比例组均与高脂组相比,大鼠下丘脑AMPK-α总蛋白表达水平明显降低,肝AMPK-α蛋白表达水平均比高脂组明显升高。结论PUFA改善血脂可能是通过增加肝AMPK表达,抑制下丘脑AMPK表达,增加肝脂肪酸氧化和抑制食欲,影响血脂代谢。     

n-6/n-3脂肪酸配方油对大鼠血脂和脂质过氧化的影响

目的研究不同脂肪酸n-6/n-3组成的配方油对大鼠血脂和脂质过氧化的影响.方法成年SD雄性大鼠喂饲含相同胆固醇(0.5%,W/W)、饱和脂肪酸(占供给能量10%)、单不饱和脂肪酸(占供给能量13%)和多不饱和脂肪酸(占供给能量12%),但不同脂肪酸n-6/n-3比(6.48、2.07、0.93、031)的4种配方油的高脂合成饲料60天,观察大鼠血脂及脂质过氧化的变化.结果4种配方油比猪油均显著降低血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、LDL-C/HDL-C、AI[(TC-HDL-C/HDL-C,致动脉粥样硬化指数)],升高HDL-C/TC;配方油D具有独特的升高血清HDL-C2的作用;配方油A、C、D显著降低血清TG,而配方油B作用不明显.以n-3多不饱和脂肪酸占优势的配方油C、D比以n-6多不饱和脂肪酸占优势的配方油A、B显著地升高血清丙二醛,降低血清超氧化物歧化酶、全血谷胱甘肽过氧化物酶活性.4组配方油大鼠的心、脑脂褐质含量均比实验前增高,各配方油间无显著差异;心、脑脂褐质与血脂的相关分析发现心、脑脂褐质与血清TC、LDL-C呈正相关,与血清高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)关系不明显.结论从预防动脉粥样硬化的角度,脂肪酸n-6/n-3比在2.07～6.48范围内是合理的脂肪酸供给模式.     

饮食n-3脂肪酸对小鼠脑脂类中多不饱和脂肪酸构成的影响

【目的】观察饮食鱼油n-3多不饱和脂肪酸(n-3 PUFAs)对脑内不同脂类中PUFAs构成的影响。【方法】使用C57BL/6J雌性小鼠,在胎儿期和幼年期分别给予不同种类高脂饲料(18%脂肪,供能比为36%)喂养-高脂豆油饲料、高脂鱼油饲料和高脂豆油:鱼油(5∶1)混合饲料,以正常饲料(6%脂肪来自豆油,供能比为12%)为对照,时间为4个月。采用薄层层析分离脑组织中各主要脂类成份,然后采用甲酯化-气相色谱分析对各脂类成份中的脂肪酸进行测定。【结果】鱼油饲料喂养改变了小鼠脑内主要脂类中PUFAs的构成。在磷脂中,虽然5种PUFAs在各饲料组之间差异均无显著性(P>0.05),但二十二碳六烯酸(DHA)/花生四烯酸(AA)(1.94±0.41)以及n-3/n-6 PUFAs比值(2.31±0.75)在鱼油组较其它三组显著升高(P<0.05);在甘油一和二酯中,与豆油组相比,鱼油组和豆油:鱼油混合组LA含量(0.31±0.09%,0.65±0.58%)降低,而鱼油组DHA/AA(2.60±1.66)以及n-3/n-6 PUFAs比值(2.31±0.75)升高(P<0.05);在甘油三酯中,与豆油组相比,鱼油组和豆油:鱼油混合组AA含量(1.62±0.53%,1.12±0.36%)和EPA含量(0.98±0.58%,1.34±0.31%)显著降低,而DHA/AA比值(1.14±0.21,1.46±0.58)升高(P<0.05),但DHA含量在三组之间无差异(P>0.05);在游离脂肪酸中,5种PUFAs在各饲料组之间无差异(P>0.05)。【结论】饮食鱼油n-3 PUFAs摄入增多虽然不影响脑内DHA的聚积,但改变了DHA/AA以及n-3/n-6PUFAs的比值。甘油酯类可能是脑摄取、聚积DHA的主要直接来源之一。     

不同n-6/n-3多不饱和脂肪酸构成比对高脂饲料喂养大鼠脂联素和糖脂代谢及抗氧化能力的影响

目的探讨高脂饲料喂养条件下,不同n-6/n-3多不饱和脂肪酸(polyunsaturated fatty acid,PUFA)构成比对大鼠脂联素和糖脂代谢及抗氧化能力的影响。方法50只雄性Wistar大鼠按体重随机分为5组:1个普通饲料组(脂肪供能比17%,n-6/n-3PUFA=5∶1)和4个高脂饲料组(脂肪供能比均为42%,n-6/n-3 PUFA构成比分别为1∶1、5∶1、10∶1、20∶1)。喂养12周后检测大鼠血糖和血脂(0、4、8和12周)、血清抗氧化指标(0和12周)以及睾周脂肪组织脂联素mRNA、蛋白表达和血清脂联素水平(12周)。结果大鼠各指标初始值组间差异均无统计学意义(P>0.05)。12周时,n-6/n-3PUFA 10∶1、20∶1组血糖显著高于对照组(P<0.05),4个高脂组血清总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)显著高于对照组(P<0.01),其中20∶1组TG显著高于其余3组(P<0.01);4个高脂组谷胱甘肽过氧化物酶和超氧化物歧化酶含量显著低于对照组(P<0.05),其中20∶1组下降最明显,丙二醛含量显著高于对照组(P<0.05),其中10∶1组上升最明显;20∶1组脂联素mRNA表达显著低于对照组、1∶1组和5∶1组(P<0.05),5∶1组脂联素蛋白表达水平显著高于其余高脂组(P<0.05),而20∶1组表达水平最低(P<0.05)。结论较低的n-6/n-3 PUFA构成比(1∶1和5∶1),有助于改善高脂饲料条件下大鼠糖脂代谢及抗氧化能力,提高脂联素表达。     

不同n-6/n-3 PUFA构成比对大鼠脂联素表达的影响及与CDK5/PPARγ关系

目的研究在膳食脂肪产热比26.52%时,不同n-6/n-3多不饱和脂肪酸(polyunsaturated fatty acids,PUFA构成比对大鼠脂联素表达的影响及CDK5/PPARγ介导的机制。方法 50只雄性Wistar大鼠按体质量(body weight, bw)随机分成对照组及4个实验组。对照组喂基础饲料,实验组分别将饲料中n-6/n-3PUFA构成比调配为1:1、5:1、10:1和20:1,测定干预前血清脂联素含量。膳食干预12w,记录体质量变化,计算食物利用率及能量转化效率,测定睾周、肾周脂肪组织重量、肾周脂肪组织脂联素表达、血清脂联素含量、肾周脂肪组织PPARγ、CDK5及p-PPARγ(Ser273)的表达。结果当n-6/n-3 PUFA构成比高于5:1,大鼠能量转化效率升高、体质量增加并伴有肾周脂肪蓄积。n-6/n-3 PUFA构成比为1:1、5:1膳食大鼠血清脂联素含量和PPARγ表达增加,CDK5、p-PPARγ蛋白降低;构成比为20:1膳食降低大鼠脂肪组织脂联素、PPARγ和CDK5蛋白的表达,且不能改变p-PPARγ蛋白表达。结论在正常的膳食脂肪供给情况下...     

n-3及n-6多不饱和脂肪酸与乳腺癌关系的Meta分析

目的 系统评价n-3多不饱和脂肪酸(n-3PUFAs)、n-6多不饱和脂肪酸(n-6PUFAs)及其比例与乳腺癌发病风险的关系。方法 系统检索Pubmed、Embase、Web of Science、知网、万方等数据库截止至2022年1月1日有关n-3及n-6多不饱和脂肪酸与乳腺癌关系的研究,对最终纳入的文献进行数据提取与质量评价,采用Stata 15.1软件进行Meta分析。结果 共纳入33项针对n-3及n-6PUFAs和乳腺癌发病风险关联的观察性流行病学研究,其中队列研究14项,病例对照研究20项,共纳入研究对象1 077 178例,患者19 207例。Meta分析结果显示:n-3多不饱和脂肪酸(OR=0.933,95%CI:0.858～1.014)、n-6多不饱和脂肪酸(OR=1.018,95%CI:0.914～1.133)与乳腺癌发病风险无统计学关联(P>0.05),而较高的n-6/n-3PUFAs比值会显著增加乳腺癌的发病风险(OR=1.166,95%CI:1.047～1.299,P=0.005)。结论 n-6/n-3多不饱和脂肪酸的比值与乳腺癌的发病风险呈正相关,提示合理的膳食脂肪摄入比可能会降低乳腺癌的患病风险。而n-3及n-6多不饱和脂肪酸与乳腺癌发病风险的单独效应关系尚不明确,仍需更多前瞻性实验流行病学证据进行支持。     

n-6/n-3 PUFA对乳腺癌大鼠ER及p53表达影响

目的 探讨不同比例的n-6/n-3多不饱和脂肪酸(PUFA)对N-甲基亚硝基脲(MNU)诱导的乳腺癌大鼠乳腺组织中雌激素受体(ER)和p53表达的影响。方法 雌性SD大鼠随机分为n-6 PUFA、10:1 n-6/n-3、5:1n-6/n-3、1:1 n-6/n-3和正常对照5组,前4组以50mg/(kg·bw)MNU单次腹腔注射诱导乳腺肿瘤发生,正常对照组注射等体积无菌生理盐水。给药后立即分组喂养不同饲料,在8和18周时处死动物,RT-PCR和蛋白印迹(Western blot)技术检测各组大鼠乳腺组织ER和p53表达。结果 4组乳腺癌大鼠乳腺组织中ER和p53的表达均较正常对照组((0.73±0.11),(0.08±0.01))有所升高,其中n-6组最高((1.32±0.18),(1.43±0.56)),其余各组随n-6/n-3比值减小而下降,1:1 n-6/n-3组((0.95±0.12),(0.12±0.06))显著低于n-6组(P<0.05)。结论 不同比例n-6/n-3多不饱和脂肪酸对MNU诱导的乳腺癌大鼠乳腺组织ER和p53的表达具有不同影响,1:1 n-6/n-3膳食脂肪酸构成能有效抑制乳腺癌大鼠乳腺组织ER和p53表达的升高。     

Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats

Dietary n-3 polyunsaturated fatty acids (PUFA) reduce coronary heart disease (CHD) complications, such as chronic arrhythmia and sudden cardiac death. Improved myocardial resistance to ischemia-reperfusion injury results in smaller myocardial infarction, which is a major factor in the occurrence of CHD complications. We hypothesized that a specific dietary fatty acid profile (low in saturated and n-6 PUFA but high in plant and marine n-3 PUFA) may improve myocardial resistance to ischemia-reperfusion injury and reduce infarct size. To test this assumption, we used a well-defined rat model of myocardial infarction. Based on our results, in comparison to a diet that is high in either saturated or n-6 PUFA but poor in plant and marine n-3 PUFA, a diet that is low in saturated fats and n-6 PUFA but rich in plant and marine n-3 PUFA results in smaller myocardial infarct size (P < .01). The effects of the 3 diets were also examined by analyzing the fatty acid composition of plasma, erythrocyte cell membranes, and the phospholipids of myocardial mitochondria. The results show a great accumulation of n-3 PUFA and a parallel decrease in arachidonic acid, the main n-6 PUFA, in plasma, cell membranes, and cardiac mitochondria (P < .0001). We conclude that improved myocardial resistance to ischemia-reperfusion may be one of the critical factors explaining the protective effects of dietary n-3 PUFA against CHD complications in humans. In addition to increasing n-3 PUFA intake, an optimal dietary pattern aimed at reducing cardiovascular mortality should include a reduction of the intake of both saturated and n-6 PUFA.     

膳食脂肪酸及n-6/n-3比与血脂及脂质过氧化关系的研究进展

膳食脂肪酸及n-6/n-3比对血脂及脂质过氧化的影响是营养学研究的重要课题,首先叙述膳食脂肪酸对血脂和脂质过氧化的影响及作用机制.然后从预防动脉粥样硬化的角度,提出建立合理的n-6/n-3脂肪酸供给比的重要性.     

n-3多不饱和脂肪酸对肥胖小鼠肠道菌群的影响

目的 探讨n-3多不饱和脂肪酸(n-3 polyunsaturated fatty acids,n-3 PUFAs)对饮食诱导肥胖小鼠肠道菌群的影响。方法 将30只3～4 周龄C57BL/ 6J雄性小鼠,随机分为3组(10只/组),分别给予高脂饲料、鱼油n-3 PUFAs高脂饲料(脂肪含量均为34.9%,供能比均为60%)以及正常脂饲料(脂肪来源于猪油和葵花籽油,脂肪含量为4.3%,供能比为10%)喂养16周。然后采集粪便,采用16sDNA-实时荧光定量PCR方法检测肠道菌群变化;取结肠组织,采用实时荧光定量PCR方法检测白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)以及单核细胞趋化蛋白-1(monocyte chemoattractant protein-1,MCP-1)的mRNA表达水平。结果 与正常脂饲料喂养对照组小鼠相比,高脂饲料诱导肥胖小鼠粪便中厚壁菌门及乳杆菌属的数量显著增多,而拟杆菌门、放线菌门、变形菌门以及双歧杆菌属的数量则显著减少(P<0.05)。两组肥胖小鼠相比,鱼油n-3 PUFAs高脂组肥胖小鼠的粪便双歧杆菌属数量明显增加,而乳杆菌属数量显著减少(P<0.05)。对结肠炎性因子mRNA表达水平检测显示,高脂饲料组肥胖小鼠的IL-1β、IL-6、TNF-α及MCP-1表达量较正常脂饲料组小鼠均明显升高(P<0.05),而IL-10的表达量无变化;鱼油n-3 PUFAs高脂饲料组肥胖小鼠的IL-1β、TNF-α较高脂饲料组肥胖小鼠有显著性的降低(P<0.05)。结论 鱼油n-3 PUFAs可以改善肥胖状态下的肠道菌群紊乱及肠道炎症状态。     

Use of microencapsulated fish oil as a means of increasing n-3 polyunsaturated fatty acid intake

Background: The successful incorporation of fish oil into foods may provide a means of increasing intakes of n-3 polyunsaturated fatty acids (n-3 PUFA). The aim of the present study was to evaluate the bioavailability of n-3 PUFA in microencapsulatd fish oil compared with a fish oil capsule. Methods: Twenty-eight healthy volunteers were recruited to take part in this randomized controlled trial. Volunteers were supplemented with 0.9 g n-3 PUFA daily for 4 weeks, delivered either as microencapsulated fish oil in a milkshake or as a fish oil capsule. Plasma fatty acid composition and plasma total cholesterol levels were measured at baseline and after supplementation. In addition, volunteers completed a questionnaire on fish consumption, use of supplements and exercise. Results: Responses to the questionnaire indicated that the males who took part in this study took more physical exercise, consumed less fish and were less likely than the females to take supplements. Plasma n-3 PUFA concentrations were raised significantly and by a similar level by both fish oil supplements. Furthermore, no significant difference was observed in plasma n-3 PUFA concentrations following supplementation with either form of fish oil. Plasma total cholesterol levels were not significantly altered by n-3 PUFA supplementation in either group. The results of this study indicated that there was no difference in the bioavailability of n-3 PUFA given as microencapsulated fish oil compared with n-3 PUFA delivered as a fish oil capsule. Fortification of foodstuffs with microencapsulated fish oil therefore offers the potential to increase intakes of n-3 PUFA in line with current recommendations.     

Lack of effect of dietary n-6:n-3 PUFA ratio on plasma lipids and markers of insulin responses in Indian Asians living in the UK

Summary Background Indian Asians living in Western Countries have an over 50 % increased risk of coronary heart disease (CHD) relative to their Caucasians counterparts. The atherogenic lipoprotein phenotype (ALP), which is more prevalent in this ethnic group, may in part explain the increased risk. A low dietary long chain n-3 fatty acid (LC n-3 PUFA) intake and a high dietary n-6 PUFA intake and n-6:n-3 PUFA ratio in Indian Asians have been proposed as contributors to the increased ALP incidence and CHD risk in this subgroup. Aim To examine the impact of dietary n-6:n-3 PUFA ratio on membrane fatty acid composition, blood lipid levels and markers of insulin sensitivity in Indian Asians living in the UK. Methods Twentynine males were assigned to either a moderate or high n-6:n-3 PUFA (9 or 16) diet for 6 weeks. Fasting blood samples were collected at baseline and 6 weeks for analysis of triglycerides, total-, LDL- and HDL-cholesterol, non-esterified fatty acids, glucose, insulin, markers of insulin sensitivity and C-reactive protein. Results Group mean saturated fatty acid, MUFA, n-6 PUFA and n-3 PUFA on the moderate and high n-6:n-3 PUFA diets were 26 g/d, 43 g/d, 15 g/d, 2 g/d and 25 g/d, 25 g/d, 28 g/d, 2 g/d respectively. A significantly lower total membrane n-3 PUFA and a trend towards lower EPA and DHA levels were observed following the high n-6:n-3 PUFA diet. However no significant effect of treatment on plasma lipids was evident. There was a trend towards a loss of insulin sensitivity on the high n-6:n- 3 PUFA diet, with the increase in fasting insulin (P = 0.04) and HOMA IR [(insulin x glucose)/ 22.5] (P = 0.02) reaching significance. Conclusion The results of the current study suggest that, within the context of a western diet, it is unlikely that dietary n-6:n-3 PUFA ratio has any major impact on the levels of LC n-3 PUFA in membrane phospholipids or have any major clinically relevant impact on insulin sensitivity and its associated dyslipidaemia. Source of support: This project was funded by the Food Standards Agency (FSA), UK.     

Incorporating macadamia oil and butter to reduce dietary omega‐6 polyunsaturated fatty acid intake

Aim: Claims have been made that the level of omega‐6 fats in the diet is too high and that this cannot be reduced without increasing the saturated fat intake. The aim of this study was to design a diet within the framework of the Australian Guide to Healthy Eating (AGHE) which would supply <2% energy (% E) from the omega‐6 polyunsaturated fatty acid (PUFA), linoleic acid, compared with the 4–5% E in the current Australian diet. Methods: Separate seven‐day diet plans were designed using FoodWorks (version 2009) for males (10 000 kJ)/day) and females (8000 kJ/day). The reduction in dietary omega‐6 PUFA content was achieved by replacing standard plant‐based oils and spreads used in cooking and baking (canola and sunflower oils) with macadamia oil and butter, and restricting the intake of some processed foods. All diets complied with the AGHE. Results: We successfully designed diets which complied with the AGHE and which had a linoleic acid (LA) content of 1.80% E and 1.75% E in females and males, respectively. In both cases, the omega‐6 : omega‐3 ratio was reduced to 5.1:1, compared with ～12:1 in the typical Australian diet, and the saturated fat content was <10% E. Conclusion: These results suggest that reducing the LA content of the diet can be readily achieved within the boundaries set by the AGHE, without an increase in saturated fat intake.